Description

This vial contains Sema, a synthetic analogue of Glucagon-Like Peptide-1 (GLP-1). This peptide is frequently utilized in research settings to investigate glucose homeostasis, insulin secretion pathways, and metabolic regulation.

Chemical Profile

This product is a high-purity (>99%), lyophilized (freeze-dried) powder requiring reconstitution. It is intended for laboratory handling and experimental analysis only.

• Component: Sema (GLP-1 Analogue)

• Total Quantity: [5mg]

• Purity: >99% (Determined by HPLC)

Quality Assurance

• HPLC Analysis: Validated >99% purity.

• Mass Spectrometry: Confirmed molecular weight and structure.

• Toxicity: Not tested for human safety.

Research Context (Literature Review)

Note: The following is for educational purposes regarding the chemical properties of these peptides and does not constitute a medical claim.

Semaglutide shares 94% structural homology with native human GLP-1 but has been modified to resist degradation by the DPP-4 enzyme. In laboratory studies, it acts as a selective agonist for the GLP-1 receptor.

Research indicates that binding to this receptor stimulates insulin secretion in a glucose-dependent manner and inhibits glucagon secretion. Additionally, animal models have shown that Semaglutide influences gastric emptying rates and signals satiety centers in the hypothalamus, making it a key compound in the study of metabolic syndrome and obesity-related pathways.

Technical Specifications